GlaxoSmithKline PLC (LSE:GSK) — Stock Price

GBX1927.50 GBX
▼ -1.68% today

GlaxoSmithKline PLC (LSE:GSK) is currently trading at GBX1927.50 GBX, down 1.68% today. Over the past 52 weeks, shares have ranged between GBX1404.50 and GBX2268.00. This page tracks GlaxoSmithKline PLC's live share price on the LSE exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see GSK market cap.

GlaxoSmithKline PLC (GSK) Stock Price Chart — Daily History & Trading Volume

The chart below tracks GlaxoSmithKline PLC's daily closing share price and trading volume on the LSE exchange over the past year, giving a clear view of recent price momentum and liquidity.

GlaxoSmithKline PLC Income Statement — Revenue, Profit & Earnings by Year

GlaxoSmithKline PLC's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20242023202220212020
Total Revenue GBX31.38 Billion GBX30.33 Billion GBX29.32 Billion GBX24.70 Billion GBX34.10 Billion
Cost of Revenue GBX9.48 Billion GBX9.08 Billion GBX9.86 Billion GBX8.35 Billion GBX10.98 Billion
Gross Profit GBX21.90 Billion GBX21.25 Billion GBX19.46 Billion GBX16.34 Billion GBX23.12 Billion
Research & Development GBX5.50 Billion GBX5.25 Billion GBX4.84 Billion GBX4.39 Billion GBX4.48 Billion
SG&A GBX11.02 Billion GBX9.38 Billion GBX8.37 Billion GBX10.97 Billion GBX11.46 Billion
Total Operating Expenses GBX16.24 Billion GBX14.26 Billion GBX12.78 Billion GBX10.94 Billion GBX14.94 Billion
Operating Income GBX5.66 Billion GBX6.99 Billion GBX6.68 Billion GBX5.41 Billion GBX8.18 Billion
EBITDA GBX6.67 Billion GBX9.14 Billion GBX8.63 Billion GBX6.45 Billion GBX10.16 Billion
EBIT GBX4.12 Billion GBX6.84 Billion GBX6.48 Billion GBX4.33 Billion GBX7.81 Billion
Interest Expense GBX644.00 Million GBX775.00 Million GBX852.00 Million GBX765.00 Million GBX876.00 Million
Income Before Tax GBX3.48 Billion GBX6.06 Billion GBX5.63 Billion GBX3.60 Billion GBX6.97 Billion
Income Tax Expense GBX526.00 Million GBX756.00 Million GBX707.00 Million GBX83.00 Million GBX580.00 Million
Net Income GBX2.58 Billion GBX4.93 Billion GBX14.96 Billion GBX4.38 Billion GBX5.75 Billion

GlaxoSmithKline PLC Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes GlaxoSmithKline PLC's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20242023202220212020
Total Assets GBX59.46 Billion GBX59.01 Billion GBX60.15 Billion GBX79.10 Billion GBX80.43 Billion
Total Current Assets GBX17.00 Billion GBX18.64 Billion GBX20.77 Billion GBX18.67 Billion GBX20.25 Billion
Cash & Equivalents — — — — —
Short-term Investments GBX21.00 Million GBX2.25 Billion GBX4.15 Billion GBX61.00 Million GBX78.00 Million
Net Receivables GBX6.93 Billion GBX5.91 Billion GBX6.22 Billion GBX7.54 Billion GBX6.59 Billion
Inventory GBX5.67 Billion GBX5.50 Billion GBX5.15 Billion GBX5.78 Billion GBX6.00 Billion
Property, Plant & Equipment — — GBX9.62 Billion GBX10.67 Billion GBX11.01 Billion
Goodwill GBX6.98 Billion GBX6.81 Billion GBX7.05 Billion GBX10.55 Billion GBX10.60 Billion
Total Liabilities GBX46.38 Billion GBX46.21 Billion GBX50.05 Billion GBX57.76 Billion GBX59.62 Billion
Total Current Liabilities GBX21.70 Billion GBX21.07 Billion GBX22.81 Billion GBX23.67 Billion GBX22.15 Billion
Long-term Debt GBX13.70 Billion GBX14.15 Billion GBX16.19 Billion GBX19.76 Billion GBX22.54 Billion
Net Debt GBX13.28 Billion GBX15.08 Billion GBX17.26 Billion GBX19.90 Billion GBX20.86 Billion
Total Stockholder Equity GBX13.67 Billion GBX13.35 Billion GBX10.60 Billion GBX15.05 Billion GBX14.59 Billion
Retained Earnings GBX7.80 Billion GBX7.24 Billion GBX4.36 Billion GBX7.94 Billion GBX6.75 Billion

GlaxoSmithKline PLC Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how GlaxoSmithKline PLC generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20242023202220212020
Operating Cash Flow GBX6.55 Billion GBX6.77 Billion GBX7.40 Billion GBX7.95 Billion GBX8.44 Billion
Capital Expenditures GBX2.98 Billion GBX2.34 Billion GBX2.26 Billion GBX2.93 Billion GBX2.24 Billion
Free Cash Flow GBX3.57 Billion GBX4.42 Billion GBX5.14 Billion GBX5.02 Billion GBX6.20 Billion
Investing Cash Flow GBX-1.23 Billion GBX-1.59 Billion GBX-8.77 Billion GBX-1.78 Billion GBX2.16 Billion
Financing Cash Flow GBX-4.73 Billion GBX-5.64 Billion GBX823.00 Million GBX-7.59 Billion GBX-10.13 Billion
Dividends Paid GBX-2.44 Billion GBX-2.25 Billion GBX3.47 Billion GBX4.00 Billion GBX3.98 Billion
Stock-Based Compensation GBX344.00 Million GBX307.00 Million GBX346.00 Million GBX367.00 Million GBX381.00 Million
Depreciation GBX2.55 Billion GBX2.29 Billion GBX2.30 Billion GBX2.52 Billion GBX624.00 Million
Change in Cash GBX545.00 Million GBX-567.00 Million GBX-394.00 Million GBX-1.44 Billion GBX431.00 Million

GlaxoSmithKline PLC Earnings History — EPS Actual vs. Analyst Estimates

Track GlaxoSmithKline PLC's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Apr 28, 2026 — — —
Feb 03, 2026 — 0.25 —
Oct 29, 2025 0.55 0.46 +19.57%
Jul 30, 2025 0.47 0.42 +11.90%
Apr 30, 2025 0.45 0.40 +12.50%
Feb 05, 2025 0.23 0.19 +21.05%
Oct 30, 2024 0.50 0.43 +16.28%
Jul 31, 2024 43.40 37.87 +14.60%